Smith Mary L. bought PTCT
July 9, 2026 · Form 4 insider transaction
Smith Mary L. bought 5,834 shares of PTC Therapeutics, Inc. at $42.95 per share, a transaction worth $250.6K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,834
Price
$42.95
Total value
$250.6K
InsiderSmith Mary L.
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 9, 2026
Filing dateJuly 13, 2026
Shares owned after27,647
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025.